Analyst Price Target is $19.88
▲ +143.12% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Avadel Pharmaceuticals in the last 3 months. The average price target is $19.88, with a high forecast of $30.00 and a low forecast of $12.00. The average price target represents a 143.12% upside from the last price of $8.18.
Current Consensus is
Buy
The current consensus among 8 polled investment analysts is to buy stock in Avadel Pharmaceuticals. This rating has held steady since May 2023, when it changed from a Moderate Buy consensus rating.